4D Molecular Therapeutics, Inc.
FDMT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001650648
In the last 90 days, 4D Molecular Therapeutics, Inc. insiders filed 0 open-market purchases and 9 sales; 157 institutions reported holding it in 13F filings for Q2 2026, worth $771.2M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in 4D Molecular Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 111
- +1 vs. Q3 2023
- Shares held
- 42.4M
- +520.1K (+1.2%) vs. Q3 2023
- Total value
- $859.8M
- +$326.3M (+61.1%) vs. Q3 2023
- New holders
- 20
- 43 more added
- Sold out
- 19
- 28 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FDMT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 157 | $771.2M |
| Q1 2026 | 153 | $471.4M |
| Q4 2025 | 153 | $400.5M |
| Q3 2025 | 134 | $343.2M |
| Q2 2025 | 121 | $149.9M |
| Q1 2025 | 126 | $139.8M |
| Q4 2024 | 146 | $260.6M |
| Q3 2024 | 140 | $629.2M |
| Q2 2024 | 143 | $1.20B |
| Q1 2024 | 147 | $1.79B |
| Q4 2023 | 111 | $859.8M |
| Q3 2023 | 110 | $533.6M |
| Q2 2023 | 100 | $745.3M |
| Q1 2023 | 94 | $522.3M |
| Q4 2022 | 96 | $621.9M |
| Q3 2022 | 88 | $210.4M |
| Q2 2022 | 90 | $181.7M |
| Q1 2022 | 80 | $395.3M |
| Q4 2021 | 77 | $541.8M |
| Q3 2021 | 63 | $515.1M |
| Q2 2021 | 56 | $400.0M |
| Q1 2021 | 64 | $664.8M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding 4D Molecular Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Novo Holdings A/S | 1,500,000 | $30.4M | 2.03% | +300,000+25.0% | Added |
| State Street Corp | 1,523,990 | $30.9M | 0.00% | −193,130−11.2% | Reduced |
| Morgan Stanley | 1,568,784 | $31.8M | 0.00% | +102,916+7.0% | Added |
| Vanguard Group Inc | 1,866,849 | $37.8M | 0.00% | −35,618−1.9% | Reduced |
| Deep Track Capital, LP | 2,284,372 | $46.3M | 1.62% | −493,735−17.8% | Reduced |
| Janus Henderson Group PLC | 3,093,296 | $62.7M | 0.04% | +346,961+12.6% | Added |
| VR Adviser, LLC | 3,424,031 | $69.4M | 4.76% | +424,031+14.1% | Added |
| BlackRock Inc. | 3,464,587 | $70.2M | 0.00% | +340,911+10.9% | Added |
| BVF Inc | 4,007,413 | $81.2M | 2.03% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 4,163,211 | $84.3M | 1.32% | 00.0% | Unchanged |
| Viking Global Investors LPSuperinvestorViking Global Investors | 4,787,914 | $97.0M | 0.36% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −650,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −331,516−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −167,137−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −160,392−100.0% | Sold out |
| GMT Capital Corp | 0 | $0 | 0.00% | −151,200−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −101,863−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −87,200−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −47,749−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −44,443−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −29,307−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −26,330−100.0% | Sold out |
| Ghisallo Capital Management LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −16,985−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −12,162−100.0% | Sold out |
| Affinity Wealth Management LLC | 0 | $0 | 0.00% | −11,471−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −11,304−100.0% | Sold out |
| Vident Advisory, LLC | 0 | $0 | 0.00% | −10,574−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −16−100.0% | Sold out |